Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30014205
Basic Information
VIS ID
TVIS30014205
Fusion event
HIV-SPATS2 integration
Validated
Yes
Detection method
invPCR
Data source
download(RID)
Sample type
PBMC
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2007
PubMed ID
17262715
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr12
Cytoband
q13.12
Reference genome
GRCh37/hg19
Start
49804993/49411210 (Hg38)
End
49804993/49411210 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
FRA12A
Target gene
SPATS2
miRNAs that regulate target gene
hsa-mir-590-3p
;
hsa-mir-103a-3p
;
hsa-mir-296-3p
;
hsa-let-7a-5p
;
hsa-mir-3154
;
hsa-mir-6873-3p
;
hsa-mir-4680-3p
;
hsa-mir-5187-3p
;
hsa-mir-4427
;
hsa-mir-3921
;
hsa-mir-4653-5p
;
hsa-mir-301b-5p
;
hsa-mir-301a-5p
;
hsa-mir-146a-3p
;
hsa-mir-7110-3p
;
hsa-mir-6817-3p
;
hsa-mir-4639-3p
;
hsa-mir-8485
;
hsa-mir-603
;
hsa-mir-1324
;
hsa-mir-4668-5p
;
hsa-mir-519e-5p
;
hsa-mir-515-5p
;
hsa-mir-5695
;
hsa-mir-519d-5p
;
hsa-mir-3613-3p
;
hsa-mir-3184-3p
Nearest miRNA
hsa-mir-1244-3/Upstream/639173; hsa-let-7i/Downstream/822932;
Nearest TSS
ENST00000382841/Upstream/43663;
ENST00000549045/Downstream/49669;
Nearest CpG islands
None/Target,
chr12-CpG: 104/Upstream/21800
,
chr12-CpG: 191/Downstream/126630
Upstream sequence
CCCATACTGATATTTAAAAtcagccacattatgggttaaatagatgtttgcatgttgacctTCTCTTTCCTTTTAGTTTCCCATCTAATGTAGTAATAGA
Downstream sequence
AAAGTTTATTGTTgttagcatactcagtcctcttgccatgtaatgcccttggtcatctcaggacacatcaaagagaacacaccagcaagaaggctcccac
Reference
Ikeda, T., et al. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy. J Infect Dis,2007, 195(5): 716-725.
Sample Information
×
Sample type
PBMC
Gender
Female
CpG Island Information
×
Download
Curate